Steris Plc (ticker:
STE) has been under the spotlight in recent investment news. Several institutional investors, such as
Villere ST Denis J & Co. LLC, found to have decreased their stake in the company but others like
Inspire Investing LLC, and
Robeco Institutional Asset Management B.V. have increased investments in STE. More shares have been bought by members such as
Rep. April McClain Delaney. Steris'
CEO Daniel Carestio made headlines selling a portion of his shares. The target price for Steris has been raised to $285 by
Piper Sandler, maintaining a 'Buy' rating. Recent earnings call highlighted
strong revenue growth and
strategic outlook for Q4 2025. Steris has outperformed the healthcare sector and there are positive views driven by
MedTech momentum. Steris announced
CFO transition, Michael J. Tokich to be succeeded by Karen L. Burton. Steris announced dividend increase for the 20th consecutive year. The company has challenged the trend with its recent 6% drop in shares, forecasting a change in the wind soon.
Steris Plc STE News Analytics from Fri, 08 Nov 2024 08:00:00 GMT to Sat, 11 Oct 2025 10:36:38 GMT -
Rating 7
- Innovation 5
- Information 7
- Rumor -1
